ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 255.88
+0.11 (0.04%)
At close: Nov 28, 2025
ResMed Market Cap
ResMed has a market cap or net worth of 28.21 billion as of November 28, 2025. Its market cap has decreased by -0.87% in one year.
Market Cap
28.21B
Enterprise Value
27.80B
Revenue
3.91B
Ranking
n/a
PE Ratio
26.37
Stock Price
255.88
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 24.33M to 28.21B, an increase of 115,832.26%. That is a compound annual growth rate of 26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 28.21B | 5.17% |
| Dec 31, 2024 | 26.82B | 35.04% |
| Dec 29, 2023 | 19.86B | -21.72% |
| Dec 30, 2022 | 25.37B | -9.78% |
| Dec 31, 2021 | 28.12B | 24.65% |
| Dec 31, 2020 | 22.56B | 34.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.70B |
| GSK plc | 71.96B |
| Haleon | 33.03B |
| Smith & Nephew | 10.64B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.44B |
| HUTCHMED (China) | 1.91B |
| Genus | 1.76B |